About Us >> Faculty >> Gina Ryan

Gina J. Ryan, Pharm.D., BCPS, CDE

Clinical Associate Professor of Pharmacy Practice

Contact Information
3001 Mercer University Drive, DV-127
Atlanta, GA 30341
(678) 547-6222
Fax: (678) 547-6384
ryan_gj@mercer.edu

Educational Background
Pharm.D., University of California at San Francisco
Pharmacy Practice Residency, University of California at San Francisco
Board Certified Pharmacotherapy Specialist
Certified Diabetes Educator

Selected Publications

Wyatt KN, Ryan GJ and Sheerin K. Reduced dose influenza vaccine. Annals of Pharmacotherapy 2006;40:1635-1639.

Ryan GJ, Martin RL, Jobe LJ. Pramlintide in the treatment of type 1 and type 2 diabetes melltius. Clinical Therapeutics 2005; 27: 1500-1512.

Ryan GJ, Chestnut R, Odegard PS, Dye JT, Jia H, Johnson JF. Diabetes concentration programs: Impact on graduates’ diabetes care services. Am J Pharm Edu. Volume 75, Issue 6, Article 112.

Ryan GJ, Foster KT, and Jobe LJ. Review of the therapeutic uses of liraglutide. Clin Ther. 2011; 33: 793-811.

Barbee M, Ryan GJ, Lundquist LM. Update on Antiplatelets The Georgia Pharmacy Journal April 2011. p21-27.

Ryan GJ and Marshall JM. Challenges in Lipid-Lowering Therapy. Available at: Power Pak CE. February 2011.

Ryan GJ and Jobe LJ. Age-Related Androgen Deficiency and Type 2 Diabetes. J of Phar Pract. 24; 316-322

Ryan GJ. Improving Adherence in Patients with Type 2 Diabetes. Available at: Power Pak CE November 15, 2010.

Ryan GJ and Hardy YM. Liraglutide: Once-daily GLP-1 agonist for the treatment of type 2 diabetes. Journal of Clinical Pharmacy and Therapeutics 2010; 36: 260–274.

Ryan GJ. Fostering patient adherence in the management of Tinea pedis. Available at: Power Pak CE. April 10, 2010.

Ryan GJ. Overcoming insulin resistance: Assisting patients in transitioning to insulin therapy. AJHP 2010;67(6):441-4.

Ryan GJ, Briscoe TM, and Jobe LJ. Review of pramlintide as adjunctive therapy in the treatment of Type 1 and Type 2 diabetes. Drug Design, Development and Therapy 2008:2;204-214.

Ryan GJ. Total cholesterol management: taking complete control. US Pharmacist/Power-Pak CE program. July 1, 2008.

Ryan GJ, Foster KT, Unterwagner WW, and Haomiao J. Impact of a Diabetes Certificate Program on PharmD Students' Knowledge and Skills. Am J Pharm Edu 2007: 71; article 84.

Ryan GJ. New pharmacologic approaches to treating diabetic retinopathy: An opportunity for pharmacist involvement in patient care. Am J Health Syst Pharm.2007; 64: S2.

Ryan GJ New pharmacologic approaches to treating diabetic retinopathy. Am J Health Syst Pharm.2007; 64: S15-S21

Roberts F and Ryan GJ. Is metformin safe in heart failure? Ann Pharmacotherapy 2007;41:642-646.

Ryan GJ, Marshall LL, Porter KB and Haomiao J. Peer, self, and faculty evaluation of class participation. Active Learning in Higher Education. 2007: 8 (1); 49-61.

Wyatt KN, Ryan GJ and Sheerin K. Reduced dose influenza vaccine. Ann of Pharmacotherapy 2006;40:1635-1639.

Ryan GJ, Marshall L, Porter K. Peer, self, and faculty class participation: the anecdotal version. Let’s Think About It Fall 2005.

Ryan GJ. Improving class participaiton: one faculty members’s experiment. Let’s Think About It Fall 2004.

Ryan GJ, Martin RL, Jobe LJ. Pramlintide in the treatment of type 1 and 2 diabetes. Clin Therap. 2005; 10: 1500-1512.

Redman AR and Ryan GJ. Aggrenox versus other pharmacotherapy in preventing recurrent stroke. Expert Opin. Pharmacotherapy. 2004;5(1):117-23.

Ryan GJ, Wanko NS, Redman AR and Cook CB. Chromium as adjunctive treatment for type 2 diabetes. Ann Pharmacotherapy 2003;37:876-85.

Erdman DM, Cook CB, Greenlund KJ, Giles WH, El-Kebbi I, Ryan GJ, Gallina DL, Ziemer DC, VDunbar VG, and Phillips LS. The impact of outpatient diabetes management on serum lipids in urban African-Americans with type 2 diabetes. Diabetes Care 2002 25: 9-15.

Redman AR and Ryan GJ. Analysis of trials evaluating combinations of acetylsalicylic acid and dipyridamole in the secondary prevention of stroke. Clin Ther 2001 Sep;23(9):1391-1408.

Ryan GJ and Nykamp D. Use of cumulative examinations at US Schools of Pharmacy. Am J Pharm Edu 2000: 64; 409-412.

Cook CB, Erdman DM, Ryan GJ et al. The pattern of dyslipidemia among urban African Americans with Type 2 diabetes. Diabetes Care 2000: 23(2); 319-324.

Ryan G and Robinson M. Dyslipidemia. US Pharmacist -Health Systems Edition 2000; 25(2): HS 39-50

Ryan G. Patient adherence in diabetes self care: The role of a pharmacist. Drug Store News. Oct 1998; CP 26-30.

Marshall LL and Ryan G. Treatment of osteoarthritis. US Pharmacist. 1998: 23(5); 50-65.

Wyatt KN, Ryan GJ and Sheerin K. Reduced dose influenza vaccine. Annals of Pharmacotherapy 2006;40:1635-1639.

Ryan GJ, Martin RL, Jobe LJ. Pramlintide in the treatment of type 1 and type 2 diabetes melltius. Clinical Therapeutics 2005; 27: 1500-1512.

Abstracts/Posters

Ryan GJ, Caudle JM, Rhee MK, Hickman JM, Tsui CW, Barnes CS, Haomia J, and Ziemer DC. Medication Reconciliation: Comparing a Customized Medication History Form to a Standard Medication Form (CAMPII 2). American College of Clinical Pharmacy Annual Meeting, October 16-19, 2011, Pittsburgh, PA, Abstract. 169

Tsui CW, Caudle JM, Ryan GJ, Barnes CS, Hickman JM, Franklin A, Ziemer DC. Design and Development of a Computer-assisted Self-interviewing Kiosk for Low-literacy Patients to Ensure Medication Safety. American Medical Informatics Association Annual Symposium, October 22-26, 2011, Washington, D.C. Abstract 0029-A2011.

Ziemer DC, Ryan GJ, Caudle JM, Barnes CS, Hickman JM, Tsui CW. Computer-Assisted Medication and Patient Information Interface (CAMPII) is Accurate and Acceptable for Medication and Hypoglycemia Detection. American Medical Informatics Association Annual Symposium, October 22-26, 2011, Washington, D.C. Abstract 0536-A2011.

Ryan GJ, Caudle JM, Tsui CW, Hickman, JM, Barnes CS, Ziemer, DC. Improving Hypoglycemia History Using Computer Aided Interview. American Diabetes Association. 71st Scientific Sessions, June 24-28, 2011, San Diego, CA. Abstract 2052.

Ryan, GJ, Chestnut R., Johnson J., et al. Practice of new pharmacists following a diabetes-emphasis curriculum versus general pharmacy education. AACP Annual Meeting 2010

Ryan GJ, Foster KT, Unterwagner W, Coffey C et al. Diabetes Certificate Program Assessment. AACP Annual Meeting 2006.

Ryan GJ, Marshall LL, Porter KB and Haomiao J. Peer, self, and faculty evaluation of class participation. AACP Annual Meeting 2005.

Ryan GJ, Nykamp D, ZT Grapes et al. Advancement Examinations at US Pharmacy Schools. ACCP Spring Forum 2000.

Woolard LM, Ryan GJ and Graff SE. Assessment of hypoglycemia patients admitted to the ECC. ASHP Midyear 1999.

Ryan GJ and Ragsdale T. Utilization of home blood glucose monitoring supplies. American Diabetes Association’s 59th Scientific Sessions 1998. No 1517.

Courses
PHA 473 Practice of Pharmacy III
PHA 474 Practice of Pharmacy IV
PHA 551 Endocrine Disorders
PHA 569 Diabetes Care
PHA 575 Practice of Pharmacy V
PHA 576 Practice of Pharmacy VI
PHA 680 Ambulatory Care


Click here for more information on Dr. Ryan.